CANNABIS M&A BUY-SIDE REPRESENTATION

Acquiring a licensed California cannabis business requires more than a purchase agreement. Every acquisition of a commercial cannabis license triggers mandatory disclosure and approval obligations under the Department of Cannabis Control’s ownership transfer regulations — and the consequences of getting it wrong include license suspension, regulatory denial, and deal collapse after closing. The Law Office of Shay Aaron Gilmore provides end-to-end buy-side representation for acquisitions of licensed cannabis and hemp businesses across California, from initial due diligence through regulatory approval and post-closing integration.

Named among the Top 20 California Cannabis Lawyers by the Daily Journal and recognized among the Top 200 Global Cannabis Lawyers by Cannabis Law Journal, Shay Aaron Gilmore brings a verified track record of closing cannabis acquisitions in California’s most complex regulatory environments — including mid-deal rescues where a prior attorney was unable to navigate the DCC’s evolving interpretation of its ownership transfer rules.

Recognized By

global top 200 cannabis logo

Global Top 200 Cannabis Lawyer

Cannabis Law Journal

The California Regulatory Framework for Cannabis Acquisitions

Under DCC Regulation §15023, a California cannabis licensee must report any change in ownership to the Department of Cannabis Control within 14 days of the effective date of the change. For acquisitions involving a new “owner” as defined under 4 CCR §15003 — meaning any person acquiring 20% or more aggregate ownership, or any person who will participate in the direction, control, or management of the business — prior regulatory approval from the DCC is required before the transaction closes.

This approval process is not merely administrative. The DCC reviews the buyer’s full ownership structure, the source of acquisition funds, the buyer’s license history and compliance record, and the suitability of the buyer to hold a cannabis license. Local jurisdictions may impose additional pre-approval requirements independent of the state process. A buyer who closes without obtaining the required regulatory approvals risks invalidating the transaction and triggering enforcement action against both buyer and seller.

The process for investors who will be “financial interest holders” rather than owners — defined under 4 CCR §15004 as persons with an aggregate ownership interest of less than 20%, persons providing loans, or persons entitled to receive 10% or more of profits — is less rigorous but still requires disclosure and may require a post-closing update to the DCC license via Form DCC LIC-027.

Buy-Side Due Diligence in Cannabis Acquisitions

Cannabis acquisition due diligence covers categories of risk that do not exist in conventional M&A. The target’s license portfolio — including whether each license is current, whether any license is under investigation or subject to a pending enforcement action, and whether each license’s local permit is independently valid — must be verified through the DCC’s public license lookup and, where necessary, a Public Records Act request for the target’s enforcement docket.

Standard buy-side diligence in a California cannabis acquisition includes:

  • DCC license status verification (state and local permits)
  • Review of prior ownership change history and all prior regulatory approvals
  • Seed-to-sale tracking compliance review (METRC/BioTrack audit)
  • Tax liability review (IRC §280E exposure, outstanding California state tax obligations, cannabis excise and cultivation tax liabilities)
  • Review of all existing investor agreements, outstanding promissory notes, SAFE agreements, and convertible instruments that will survive closing or require payoff
  • Regulatory approval timeline mapping (state + all affected local jurisdictions)
  • Representation and warranty framework — the NVCA Stock Purchase Agreement (updated October 2025) provides a well-tested template for rep-and-warranty allocation that is commonly adapted for cannabis acquisitions, with cannabis-specific modifications
  • Management rights and board composition review per the NVCA Voting Agreement (updated October 2025) where the target has existing VC-backed equity structure
  • Review of any NVCA Right of First Refusal and Co-Sale Agreement provisions held by existing investors that could affect the buyer’s ability to acquire the target
  • Post-closing indemnification — the NVCA Indemnification Agreement (updated July 2020) is used for director-level indemnification where new board members are added at closing

Cannabis vs. Hemp Acquisition Comparison

Issue Cannabis Acquisition Hemp Acquisition
Regulatory approval required Yes — DCC pre-approval for ownership changes (4 CCR §15023) No state license transfer approval required; CDFA registration update only
License transferability License is non-transferable; buyer must obtain DCC approval for ownership change CDFA hemp registration is issued to the grower; new grower must register independently
Due diligence emphasis License compliance, DCC enforcement history, 280E tax exposure Crop insurance, CDFA registration history, THC testing compliance (0.3% threshold)
Financing instruments SAFE notes, preferred stock, secured debt — all trigger FIH disclosure to DCC Conventional commercial financing; no state disclosure obligations
Deal timeline 3–9 months depending on local pre-approval requirements 30–60 days typical for asset purchase
Federal law exposure Schedule I — no federal bankruptcy protection; federal court venue complications Schedule V equivalent (Farm Bill compliant); conventional federal law applies

Representative Matters

Represented the buyer in negotiating the acquisition of a subsidiary of one of the largest publicly traded cannabis companies in the United States at the time.

Represented the buyer in the acquisition of a Long Beach cannabis manufacturing company.

Represented the buyer in the acquisition of a cannabis manufacturing and distribution company in Ukiah, California.

Frequently Asked Questions

Yes, if you will become an “owner” as defined under 4 CCR §15003 — meaning you will hold 20% or more of the licensed entity or will participate in directing, controlling, or managing the business — the DCC requires regulatory approval before closing. Local jurisdictions may impose additional pre-approval requirements independent of the state process. Failing to obtain pre-approval can result in the transaction being invalidated and enforcement action against both buyer and seller.
Buy-side due diligence in a California cannabis acquisition covers license verification (state and local permits), seed-to-sale compliance review, IRC §280E and California tax liability analysis, review of existing investor agreements and convertible instruments, and a regulatory approval timeline mapping across all affected state and local jurisdictions. The NVCA Stock Purchase Agreement (updated October 2025) provides a widely-used template for rep-and-warranty allocation that is commonly adapted with cannabis-specific modifications.
Deal timelines vary significantly by the number of licenses involved and local jurisdiction pre-approval requirements. Transactions involving a single license in a jurisdiction with a streamlined pre-approval process may close in 3–4 months. Multi-license transactions or deals in jurisdictions with extended pre-approval timelines — such as San Francisco or Los Angeles — can run 6–9 months or longer. Regulatory approval timeline mapping at the outset of a transaction is essential for setting realistic closing expectations.
Yes, and the structure choice has significant regulatory and tax implications. In an asset purchase, the DCC license does not automatically transfer — the buyer must still obtain regulatory approval for the change in ownership of the licensed business. An asset purchase may allow the buyer to step up the tax basis of acquired assets, which is meaningful given that 280E disallows deductions at the federal level. The optimal structure depends on the specific licenses, jurisdictions, and tax position of both parties.
Unresolved 280E tax liabilities are among the most significant deal risks in cannabis acquisitions. If the liabilities attach to the entity, they survive a stock acquisition and become the buyer’s problem post-closing. Buy-side due diligence should include a full review of federal and California tax returns, outstanding IRS and FTB assessments, and any open audits. In some transactions, the seller may agree to establish an escrow holdback to cover potential 280E exposure identified during diligence.

Helpful Resources & Related Pages

Explore related venture capital, M&A, and investment legal services

Related Venture Capital Counsel Pages:

Exit planning and sell-side counsel for licensed California cannabis operators
Investor-side representation including secured loans and creditor restructurings
SAFE notes, convertible instruments, and Regulation D compliance

Other Services

Corporate law for cannabis acquisitions, mergers, and business transfers
Entity structuring for cannabis businesses and their investors
Property-level due diligence for cannabis acquisitions